The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
A SENIOR healthcare lawyer at McKenna & Co has called for medical product pricing decisions to be kept out of court after his firm's successful action on vitamin prices.
Healthcare partner Gary Hickinbottom said the Office of Fair Trading was best placed to resolve the public interest issues involved.
His comments come after McKennas won injunctions on behalf of Roche Products and Seven Seas, halting last month's attempt by supermarket chain Asda to cut the prices of vitamins and food supplements below the retail price maintenance level.
Asda gave undertakings to restore the prices to the "proper and contractual" level. The OFT is investigating the price cuts.
Hickinbottom said: "The proper forum for the serious and complex public interest issues raised by retail price maintenance is not the ordinary courts but the OFT, which has a duty to keep the public interest as paramount.
"In the meantime it is only right that retailers comply with their contracts which lawfully contain proper retail price maintenance clauses."